These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16298967)
1. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. Peng J; Zhao Y; Mai J; Pang WK; Wei X; Zhang P; Xu Y J Gen Virol; 2005 Dec; 86(Pt 12):3227-3234. PubMed ID: 16298967 [TBL] [Abstract][Full Text] [Related]
2. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo. Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAs. Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Scherman D; Escriou V; Arbuthnot P J Control Release; 2015 Jul; 209():198-206. PubMed ID: 25937322 [TBL] [Abstract][Full Text] [Related]
4. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice. Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029 [TBL] [Abstract][Full Text] [Related]
5. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586 [TBL] [Abstract][Full Text] [Related]
6. Countering hepatitis B virus infection using RNAi: how far are we from the clinic? Ivacik D; Ely A; Arbuthnot P Rev Med Virol; 2011 Nov; 21(6):383-96. PubMed ID: 21913277 [TBL] [Abstract][Full Text] [Related]
7. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference. Cheng TL; Chang WW; Su IJ; Lai MD; Huang W; Lei HY; Chang WT Biochem Biophys Res Commun; 2005 Oct; 336(3):820-30. PubMed ID: 16153600 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells. Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826 [TBL] [Abstract][Full Text] [Related]
10. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells. Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962 [TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA inhibits hepatitis B virus replication in mice. Giladi H; Ketzinel-Gilad M; Rivkin L; Felig Y; Nussbaum O; Galun E Mol Ther; 2003 Nov; 8(5):769-76. PubMed ID: 14599810 [TBL] [Abstract][Full Text] [Related]
12. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs. Xuan B; Qian Z; Hong J; Huang W Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421 [TBL] [Abstract][Full Text] [Related]
13. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains. Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641 [TBL] [Abstract][Full Text] [Related]
14. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice. Shin D; Kim SI; Kim M; Park M Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303 [TBL] [Abstract][Full Text] [Related]
15. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1. Jenke AC; Wilhelm AD; Orth V; Lipps HJ; Protzer U; Wirth S Antimicrob Agents Chemother; 2008 Jul; 52(7):2355-9. PubMed ID: 18474581 [TBL] [Abstract][Full Text] [Related]
16. [Effects of amantadine and biphenyl dimethyl dicarboxylate on hepatitis B virus in hepatitis B virus replication mice]. Liu F; Jiang Z; Zhou Q; Yu Y; Meng H; Shi Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Apr; 31(2):400-4. PubMed ID: 25039150 [TBL] [Abstract][Full Text] [Related]
17. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HBV replication and gene expression in vitro and in vivo with a single AAV vector delivering two shRNA molecules. Li Z; He ML; Yao H; Dong QM; Chen YC; Chan CY; Zheng BJ; Yuen KY; Peng Y; Sun Q; Yang X; Lin MC; Sung JJ; Kung HF BMB Rep; 2009 Jan; 42(1):59-64. PubMed ID: 19192395 [TBL] [Abstract][Full Text] [Related]
19. [Inhibition of hepatitis B virus replication and expression by RNA interference in vivo]. Ying RS; Fan XG; Zhu C; Li N; Zhang BX Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):15-8. PubMed ID: 16420758 [TBL] [Abstract][Full Text] [Related]
20. Establishment and primary application of a mouse model with hepatitis B virus replication. Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]